
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?On the show
From 37 epsHosts
Not detected.
Recent guests
Recent episodes
Robert W. Frenck Jr., MD / Flor M. Munoz, MD - Equitable Vaccination Practices for Pediatric and Adolescent Populations: Balancing Barriers, Bias, and Benefits
Oct 9, 2026
1h 05m 09s
Pam R. Taub, MD, FACC, FASPC - Managing ASCVD From the Inside Out: Comprehensive Strategies for Getting the Most From Innovative Lipid-Lowering Therapies
Oct 5, 2026
52m 25s
Tuan H. Vu, MD - Generalized Myasthenia Gravis Across Serological Subtypes: Challenges in Diagnosis and Treatment Personalization
Oct 5, 2026
59m 45s
Thomas S. Higgins, MD, MSPH, MBA - An Individualized Approach in CRSwNP: Precision Medicine in Action
Sep 28, 2026
28m 14s
Donna H. Ryan, MD, FTOS / Angela Ritten, DNP, APRN, FNP-BC - Treating Beyond the Scale: Personalized, Evidence-Based Strategies for Comprehensive Management of Obesity as a Chronic Disease
Aug 31, 2026
1h 05m 09s
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Based on the show's feed history.
Built from
By chart position
- 🇲🇾MY · Science#182420 to 3.8K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
420 to 3.8K🎙 Daily cadence·394 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
1.4K to 13K🇺🇸71%🇲🇾29% - Active Followers
Loyal subscribers who consistently listen
770 to 6.9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 10/9/26 | Robert W. Frenck Jr., MD / Flor M. Munoz, MD - Equitable Vaccination Practices for Pediatric and Adolescent Populations: Balancing Barriers, Bias, and Benefits | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BTQ865. CME/MOC/AAPA/IPCE credit will be available until September 28, 2027.Equitable Vaccination Practices for Pediatric and Adolescent Populations: Balancing Barriers, Bias, and Benefits In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation. | 1h 05m 09s | ||||||
| 10/5/26 | Pam R. Taub, MD, FACC, FASPC - Managing ASCVD From the Inside Out: Comprehensive Strategies for Getting the Most From Innovative Lipid-Lowering Therapies | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BMW865. CME credit will be available until September 28, 2027.Managing ASCVD From the Inside Out: Comprehensive Strategies for Getting the Most From Innovative Lipid-Lowering Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation. | 52m 25s | ||||||
| 10/5/26 | Tuan H. Vu, MD - Generalized Myasthenia Gravis Across Serological Subtypes: Challenges in Diagnosis and Treatment Personalization | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/CVA865. CME/NCPD/AAPA credit will be available until September 22, 2027.Generalized Myasthenia Gravis Across Serological Subtypes: Challenges in Diagnosis and Treatment Personalization In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from argenx US, Inc.Disclosure information is available at the beginning of the video presentation. | 59m 45s | ||||||
| 9/28/26 | Thomas S. Higgins, MD, MSPH, MBA - An Individualized Approach in CRSwNP: Precision Medicine in Action | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/DAC865. CME/MOC/CC/AAPA credit will be available until September 22, 2027.An Individualized Approach in CRSwNP: Precision Medicine in Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation. | 28m 14s | ||||||
| 8/31/26 | obesity managementchronic disease+3 | Donna H. Ryan, MD, FTOSAngela Ritten, DNP, APRN, FNP-BC | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | obesitychronic disease management+3 | Lilly | 1h 05m 09s | ||
| 8/31/26 | biologic therapyCRSwNP+3 | Joseph K. Han, MD, FARS, FAAAAIAnju T. Peters, MD, MS | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | biologic therapyCRSwNP+3 | Regeneron Pharmaceuticals, Inc | 34m 00s | ||
| 8/14/26 | cognitive healthcollaborative workflows+3 | Chuck Vega, MD, FAAFP | PVI, PeerView Institute for Medical EducationGerontological Society of America+3 | — | cognitive healthhealthcare professionals+3 | Lilly | 45m 24s | ||
| 8/14/26 | shared decision-makingunresectable stage III NSCLC+3 | Prof. Sanjay PopatAndreas Rimner | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | NSCLCEGFRm+3 | AstraZeneca | 36m 28s | ||
| 8/4/26 | Cognitive HealthAlzheimer's Disease+4 | Jared R. Brosch, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Cognitive HealthAlzheimer's Disease+5 | Lilly | 1h 09m 17s | ||
| 8/4/26 | MEK Inhibitor TherapyNeuro-Oncology+3 | Jim WhittleKatie Metrock | PeerView Institute for Medical EducationMerck KGaA+3 | — | MEK InhibitorNF1+3 | SpringWorks | 43m 27s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 8/4/26 | Pulmonary Arterial HypertensionPrimary Care+3 | Vallerie V. McLaughlin, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | PAHhealthcare professionals+3 | Merck & Co., Inc. | 58m 05s | ||
| 7/20/26 | neuroendocrine tumorssystemic therapy+3 | Jennifer Chan, MD, MPH | PVI, PeerView Institute for Medical EducationNeuroendocrine Cancer Awareness Network+3 | — | neuroendocrine tumorssystemic therapy+5 | Exelixis, Inc. | 1h 03m 19s | ||
| 7/13/26 | HIV ManagementTherapeutic Advances+3 | Paul E. Sax, MDEileen Scully, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | HIVpatient care+3 | Merck & Co., Inc. | 1h 03m 22s | ||
| 7/13/26 | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Philip J. Mease, MD, MACR | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Alnylam Pharmaceuticals, Inc. | 53m 04s | ||
| 7/13/26 | metastatic EGFRm NSCLCemerging strategies+3 | Maximilian Johannes Hochmair, MDZosia Piotrowska, MD, MHS | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | EGFRm NSCLCmetastatic cancer+3 | AstraZeneca | 31m 24s | ||
| 7/13/26 | ImmunotherapyMelanoma+3 | Hussein Tawbi, MD, PhD | PVI, PeerView Institute for Medical Education | Rahway, NJ, USA | immunotherapymelanoma+5 | Bristol Myers Squibb | 1h 33m 29s | ||
| 7/8/26 | Seronegative Generalized Myasthenia GravisPersonalized Treatment+3 | Neelam Goyal, MDGil I. Wolfe, MD, FAAN | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Myasthenia GravisCME+5 | argenx US, Inc. | 47m 19s | ||
| 7/8/26 | Type 2 Diabetes ManagementEvidence-Based Practice+3 | Javier Morales, MD, FACP, FACE | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesHealthcare Professionals+3 | Lilly | 1h 03m 51s | ||
| 7/2/26 | Multiple SclerosisBTK Inhibition+3 | Jiwon Oh, MD, PhD, FRCPCGregory F. Wu, MD, PhD, FAAN | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+3 | — | Multiple SclerosisBTK Inhibition+3 | Genentech | 58m 11s | ||
| 6/25/26 | Type 2 DiabetesBasal Insulin+3 | Athena Philis-Tsimikas, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesBasal Insulin+3 | Lilly | 34m 46s | ||
| 6/15/26 | Long-Acting PrEPHealthcare Education+3 | Colleen F. Kelley, MD, MPH | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Long-Acting PrEPHealthcare Professionals+5 | Gilead Sciences, Inc. | 33m 47s | ||
| 6/15/26 | Jordan Mast, MMS, PA-C - Lighting the Way to Patient-Centered Alzheimer’s Care: Employing Amyloid-Targeting Therapies Safely and Effectively Through Careful Patient Selection and Shared Decision-Making | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/CDR/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/FUS865. CME/MOC/NCPD/AAPA/ASWB-ACE/CDR/APA/IPCE credit will be available until June 17, 2027.Lighting the Way to Patient-Centered Alzheimer’s Care: Employing Amyloid-Targeting Therapies Safely and Effectively Through Careful Patient Selection and Shared Decision-Making In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Gerontological Society of America. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | 1h 15m 25s | ||||||
| 6/15/26 | Amy M. Klingler, MS, PA-C, DFAAPA - Keeping Brain Health Top of Mind: Preserving Cognition and Improving Early Detection and Diagnosis of Alzheimer’s Disease | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/CDR/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/QRA865. CME/MOC/NCPD/AAPA/ASWB-ACE/CDR/APA/IPCE credit will be available until June 15, 2027.Keeping Brain Health Top of Mind: Preserving Cognition and Improving Early Detection and Diagnosis of Alzheimer’s Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Gerontological Society of America. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | 1h 16m 05s | ||||||
| 6/5/26 | Polycythemia VeraHepcidin Pathway+3 | Andrew Kuykendall, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Polycythemia VeraHepcidin+5 | Takeda Pharmaceuticals U.S.A., Inc. | 31m 52s | ||
| 5/29/26 | Inflammatory Bowel DiseaseTL1A Inhibition+4 | Anita Afzali, MD, MPH, MHCM, FACG, AGAFJessica R. Allegretti, MD, MPH, FACG, AGAF+1 | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Inflammatory Bowel DiseaseTL1A Inhibition+5 | Merck & Co., Inc. | 1h 10m 58s | ||
| 5/29/26 | Acute Lymphoblastic LeukemiaBispecific Options+3 | Ibrahim Aldoss, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Acute Lymphoblastic Leukemiabispecific therapy+4 | AstraZeneca | 37m 51s | ||
| 5/29/26 | Chronic Spontaneous UrticariaHealthcare Education+3 | Adam Friedman, MD, FAAD | University of CincinnatiAccreditation Council for Continuing Medical Education (ACCME)+1 | — | Chronic Spontaneous UrticariaCME+3 | Novartis Pharmaceuticals Corporation | 55m 16s | ||
| 5/29/26 | cognitive declinedementia risk+3 | Anna Chodos, MD, MPH | PVI, PeerView Institute for Medical EducationBrightFocus Foundation+3 | — | cognitive declinedementia+5 | Lilly | 46m 16s | ||
| 5/25/26 | Type 2 DiabetesBasal Insulin+3 | Athena Philis-Tsimikas, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesBasal Insulin+5 | Lilly | 1h 08m 39s | ||
| 5/25/26 | RSV PreventionPediatric Care+3 | Asuncion Mejias, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | Rahway, NJ, USA | RSVpediatric+4 | Merck & Co., Inc. | 1h 04m 50s | ||
| 5/25/26 | Alzheimer's DiseaseDetection+4 | Professor Frank Jessen, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Alzheimer's DiseaseCME+4 | Lilly | 31m 48s | ||
| 5/12/26 | Transthyretin Cardiac AmyloidosisInternal Medicine+3 | Julie L. Rosenthal, MD, FACCRonald Witteles, MD, FACC | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Transthyretin Cardiac Amyloidosisinternal medicine+3 | Alnylam Pharmaceuticals, Inc. | 59m 02s | ||
| 5/12/26 | retinal treatmentanti-VEGF therapies+3 | Christina Y. Weng, MD, MBA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+3 | — | retinal treatmentanti-VEGF+3 | Genentech | 35m 36s | ||
| 5/7/26 | Alzheimer's DiseaseAPOE Status+4 | Professor Christopher ChenProfessor Atsushi Iwata, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Alzheimer's DiseaseAPOE+4 | Lilly | 45m 04s | ||
| 5/7/26 | Parkinson's DiseasePsychosis+3 | — | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Parkinson's Diseasepsychosis+5 | ACADIA Pharmaceuticals Inc. | 56m 47s | ||
| 5/7/26 | Psoriasis careOral IL-23 inhibitors+3 | April W. Armstrong, MD, MPH | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | psoriasisIL-23 inhibitors+3 | Johnson & Johnson | 33m 41s | ||
| 5/7/26 | Restless Legs SyndromeTreatment Guidelines+3 | J. Andrew Berkowski, MD, FAASM | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Restless Legs Syndrometreatment gaps+5 | Noctrix Health, Inc. | 46m 37s | ||
| 5/7/26 | Incretin-based therapiesType 2 diabetes+3 | Jay H. Shubrook, DO, FAAFP, FACOFP | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | incretinType 2 diabetes+3 | Lilly | 1h 25m 04s | ||
| 4/27/26 | MDD ManagementPrimary Care+3 | Charles Vega, MD, FAAFP | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | MDDPrimary Care+3 | Johnson & Johnson | 1h 04m 28s | ||
| 4/15/26 | shingles preventionimmunization strategies+3 | Catherine DuntonCraig Noronha | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | shinglesimmunization+3 | GSK | 25m 45s | ||
| 3/24/26 | lung cancer screeningdiverse populations+4 | Michael R. Gieske, MDNichole T. Tanner, MD, MSCR | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | lung cancerscreening+4 | Lilly | 53m 38s | ||
| 3/24/26 | perennial allergic rhinitistargeted treatment approaches+3 | Ellen R. Sher, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | allergic rhinitishealthcare professionals+3 | Lilly | 56m 30s | ||
| 3/24/26 | Psoriatic ArthritisTYK2 Inhibition+3 | Philip J. Mease, MD, MACR | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Psoriatic ArthritisTYK2 Inhibition+5 | Bristol Myers Squibb | 51m 14s | ||
Showing 43 of 394
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.